Kamada CEO to Present at 2025 Wells Fargo Healthcare Conference.

Kamada Ltd. CEO Amir London will participate in the 2025 Wells Fargo Healthcare Conference and the H.C. Wainwright 27th Annual Global Investment Conference. London will present at the Wells Fargo conference on September 3, 2025, and be available for one-on-one investor meetings. A live webcast of the presentation is available at the link provided.

Kamada Ltd. (NASDAQ: KMDA), a life sciences company, has announced that its CEO, Amir London, will participate in the 2025 Wells Fargo Healthcare Conference and the H.C. Wainwright 27th Annual Global Investment Conference. CEO London will present at the Wells Fargo conference on September 3, 2025, and will be available for one-on-one investor meetings. A live webcast of the presentation will be available at the link provided.

This event comes at a critical time for Kamada, as the company continues to expand its operations and demonstrate strong financial performance. In the first half of 2025, Kamada reported total revenue of $88.8 million, a 11% year-over-year increase, with adjusted EBITDA of $22.5 million and a 25% EBITDA margin [3]. The company's earnings expansion cycle, coupled with its cash-generative nature, has attracted the attention of investors seeking low-speculative biotech names [3].

At the Wells Fargo Healthcare Conference, CEO London is expected to provide an update on Kamada's strategic growth pillars, including its organic expansion and core infrastructure investments. The company's recent FDA approval of the Houston plasma collection center, with a 50,000-liter annual capacity and potential revenue of $8-$10 million, is a notable milestone that adds vertical integration and margin optionality [3].

Kamada's strong valuation metrics, such as a P/E ratio of 17.23 and a P/B ratio of 1.55, also make it an attractive option for value investors. The company's P/S ratio of 2.35 is significantly lower than the industry average of 5.57, further underscoring its undervalued status [1].

Investors interested in attending the presentation or learning more about Kamada's latest developments can visit the live webcast link provided. CEO London's participation in these high-profile conferences highlights Kamada's growing influence in the healthcare sector and its commitment to transparent communication with investors.

References:
[1] https://www.nasdaq.com/articles/should-value-investors-buy-kamada-kmda-stock-0
[2] https://english.aawsat.com/business/5181617-minister-transport-inaugurates-fedex-global-head-office-saudi-arabia
[3] https://seekingalpha.com/article/4817227-kamada-earnings-expansion-cycle-with-embedded-margin-of-safety